STRATA Skin Sciences, Inc.
SSKN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $34 | $33 | $36 | $30 |
| % Growth | 0.6% | -7.8% | 20.6% | – |
| Cost of Goods Sold | $14 | $15 | $14 | $10 |
| Gross Profit | $19 | $18 | $22 | $20 |
| % Margin | 56.9% | 55.3% | 60.2% | 66.2% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $11 | $11 | $10 | $10 |
| SG&A Expenses | $24 | $23 | $25 | $23 |
| Sales & Mktg Exp. | $12 | $13 | $15 | $13 |
| Other Operating Expenses | $4 | $2 | $0 | $0 |
| Operating Expenses | $28 | $27 | $26 | $24 |
| Operating Income | -$9 | -$9 | -$5 | -$4 |
| % Margin | -27.6% | -25.8% | -12.9% | -14.7% |
| Other Income/Exp. Net | -$1 | -$2 | -$1 | $2 |
| Pre-Tax Income | -$10 | -$11 | -$5 | -$3 |
| Tax Expense | -$0 | -$0 | $0 | $0 |
| Net Income | -$10 | -$11 | -$6 | -$3 |
| % Margin | -30.1% | -32.5% | -15.3% | -9% |
| EPS | -0.26 | -0.31 | -0.16 | -0.08 |
| % Growth | 16.1% | -93.8% | -101.3% | – |
| EPS Diluted | -0.26 | -0.31 | -0.16 | -0.08 |
| Weighted Avg Shares Out | 38 | 35 | 35 | 34 |
| Weighted Avg Shares Out Dil | 38 | 35 | 35 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $1 | $0 |
| Depreciation & Amortization | $5 | $6 | $6 | $4 |
| EBITDA | -$3 | -$3 | $1 | $2 |
| % Margin | -8.5% | -10.1% | 3.1% | 5.8% |